Choose Hexarelin Vial Size — Dosing & Storage Guide

Most researchers working with hexarelin focus on dosing precision—micrograms per kilogram, injection timing, receptor saturation thresholds. What they don't plan for: vial size mismatch. A 5mg vial costs less per milligram than a 2mg vial, but if your protocol spans two months and you reconstitute the entire 5mg supply on day one, you'll hit the 28-day bacteriostatic water stability window halfway through. The second half of that vial? Degraded peptide with unknown potency. We've reviewed peptide procurement patterns across research labs running GHRP protocols—the single biggest source of wasted compound isn't contamination or injection error. It's buying vial sizes that don't match reconstitution shelf life to protocol duration.

Our team works directly with institutions running hexarelin in metabolic research, muscle preservation studies, and neuroprotection trials. The gap between theoretical dosing and actual usable peptide comes down to one decision most researchers make without enough information: which vial size to order before they've calculated their reconstitution schedule.

How do you choose hexarelin vial size for research protocols?

Choose hexarelin vial size by matching total milligrams to your protocol duration and dosing frequency, ensuring the reconstituted peptide is fully used within 28 days of mixing with bacteriostatic water. A 200mcg daily dose over 4 weeks requires 5.6mg total—a single 5mg vial falls short, while a 10mg vial leaves 4.4mg unused unless split across two reconstitution cycles. Calculate total protocol demand first, then select the smallest vial size that covers it without requiring storage beyond the 28-day refrigerated stability window.

Here's what most peptide guides won't tell you: vial size isn't about cost efficiency—it's about minimizing exposure to the two factors that degrade hexarelin faster than anything else. Temperature excursions above 8°C and time in aqueous solution. Lyophilized hexarelin stored at -20°C remains stable for years. Once you add bacteriostatic water, the clock starts—and it's a 28-day countdown, not a suggestion. This article covers how to calculate your exact hexarelin demand, why smaller vials often outperform bulk orders, and what reconstitution schedules actually look like when you choose hexarelin vial size correctly.

Hexarelin Stability and Reconstitution Constraints

Hexarelin (His-D-2-methyl-Trp-Ala-Trp-D-Phe-Lys-NH2) is a synthetic growth hormone-releasing peptide with a half-life of approximately 70 minutes in vivo—but stability in storage is an entirely different consideration. Lyophilized hexarelin stored at -20°C in sealed vials maintains >98% purity for 24–36 months according to accelerated stability testing published by peptide manufacturers. The moment you reconstitute it with bacteriostatic water (0.9% benzyl alcohol), two degradation pathways activate: oxidative modification of the tryptophan residues at positions 2 and 4, and hydrolytic cleavage at peptide bonds under aqueous conditions. Benzyl alcohol slows microbial growth—it doesn't stop peptide degradation. Refrigeration at 2–8°C extends usability to roughly 28 days, but that window isn't negotiable. After four weeks, potency loss accelerates. Some researchers assume freezing reconstituted peptide extends this timeline—it doesn't. Freeze-thaw cycles cause aggregation and precipitation, rendering the peptide unusable even if it appears clear.

When you choose hexarelin vial size, you're choosing how much peptide you'll expose to this 28-day degradation window. A 10mg vial reconstituted all at once for a protocol requiring 200mcg daily gives you 50 doses—but you'll only use 28 of them within the stability period. The remaining 22 doses (4.4mg of peptide) degrade past reliable potency. Smaller vials—2mg or 5mg—allow you to reconstitute only what the protocol demands within one stability cycle, then reconstitute a second vial for the next phase. This approach costs slightly more per milligram upfront but eliminates waste from degraded peptide. Most researchers ordering research-grade peptides don't run this calculation before purchasing—and the mismatch shows up as unexplained variability in results halfway through a study.

Calculating Total Hexarelin Demand for Your Protocol

Protocol duration and dosing frequency determine total milligram demand—everything else is downstream. A standard research protocol for hexarelin uses 100–200mcg per dose, administered once or twice daily depending on the study design. Twice-daily dosing (morning fasted, post-workout or pre-sleep) at 200mcg per injection totals 400mcg daily. Over an 8-week protocol, that's 22.4mg total hexarelin. If you order a single 10mg vial, you'll need to order a second vial mid-protocol anyway—and reconstitute it separately to respect the 28-day stability rule. Ordering two 10mg vials upfront means the first vial is reconstituted and depleted within 25 days (10mg ÷ 0.4mg daily), then the second vial is reconstituted fresh for the remaining 31 days of the protocol. No waste. No guessing about potency loss.

Now compare that to a researcher who orders one 20mg vial to "save money." They reconstitute the entire vial on day one. By day 28, they've used 11.2mg—leaving 8.8mg in the vial. The protocol runs another 28 days, but that remaining peptide has been sitting in bacteriostatic water for a month. Potency is compromised. Results become unreliable. When you choose hexarelin vial size without matching it to your reconstitution schedule, you introduce an uncontrolled variable into your study design.

For single-dose-per-day protocols (100mcg daily), an 8-week study requires 5.6mg total. A 5mg vial falls short—you'd need a second smaller vial or accept running one week under target dose. A 10mg vial overshoots by 4.4mg unless you extend the protocol or split reconstitution. The cleanest solution: two 5mg vials, reconstituted sequentially. First vial covers days 1–50 at 100mcg daily, second vial (reconstituted on day 29) covers days 29–56. Both vials stay within the 28-day window. No degraded peptide. No compromised data.

Vial Size Comparison for Common Research Protocols

Key Takeaways

• Reconstituted hexarelin maintains reliable potency for 28 days refrigerated at 2–8°C—after that, degradation accelerates and results become uncontrolled.
• A 200mcg twice-daily protocol over 8 weeks requires 22.4mg total hexarelin, best covered by two 10mg vials reconstituted sequentially to respect stability windows.
• Buying larger vials to reduce per-milligram cost introduces waste if total demand doesn't align with the 28-day post-reconstitution shelf life.
• Calculate your exact protocol demand (daily dose × number of days) before selecting vial size—smallest vial configuration that covers demand without exceeding one stability cycle per vial is optimal.
• Freezing reconstituted peptide to extend shelf life causes aggregation and potency loss—refrigeration is the only validated storage method post-reconstitution.

What If: Hexarelin Vial Size Scenarios

What If I Ordered a 10mg Vial But My Protocol Only Needs 6mg?

Reconstitute only the amount you'll use within 28 days, then store the remaining lyophilized powder at -20°C. Hexarelin as a lyophilized solid is stable for years—there's no requirement to reconstitute an entire vial at once. Use aseptic technique to withdraw bacteriostatic water into the vial for partial reconstitution: if the vial contains 10mg and you add 2mL of bacteriostatic water, you've created a 5mg/mL solution. Withdraw 1.2mL (6mg) for your protocol, then re-seal and freeze the dry powder that remains. The challenge: maintaining sterility during partial reconstitution requires a laminar flow hood or at minimum a properly sanitized work surface and alcohol-wiped vial stoppers. Most research settings don't have the equipment to do this cleanly, which is why ordering the correct vial size from the start eliminates the problem.

What If I'm Stacking Hexarelin with Other Peptides—Does That Change Vial Size Selection?

Yes, if you're running hexarelin alongside other growth hormone secretagogues like GHRP-2 or MK-677, your injection frequency increases and total hexarelin demand per cycle may decrease. A stack protocol might use 100mcg hexarelin in the morning and 100mcg GHRP-2 pre-sleep, rather than 200mcg hexarelin twice daily. That cuts hexarelin demand in half—for an 8-week stack, you'd need 5.6mg hexarelin instead of 11.2mg. Choosing hexarelin vial size for stacked protocols means accounting for reduced per-peptide volume while still respecting the 28-day reconstitution window for each compound. Two 5mg vials—one hexarelin, one GHRP-2—reconstituted on the same day keeps both peptides within their stability windows and avoids the complexity of staggered reconstitution schedules.

What If My Hexarelin Vial Arrived at Room Temperature—Is It Still Usable?

Lyophilized hexarelin tolerates brief temperature excursions during shipping better than reconstituted peptide, but "brief" means 24–48 hours maximum at temperatures up to 25°C. If the vial arrived warm but the shipping timeline was under two days, the peptide is likely still viable—store it at -20°C immediately and reconstitute as planned. If shipping took longer or the package sat in a hot delivery truck for an extended period, request a replacement. Temperature loggers included with premium peptide shipments remove the guesswork—if the logger shows the package exceeded 25°C for more than 48 cumulative hours, the peptide's integrity is questionable. When you choose hexarelin vial size from suppliers who include cold packs and temperature monitoring, you're paying for the assurance that what arrives matches the purity tested at the source.

The Blunt Truth About Hexarelin Vial Size

Here's the honest answer: most researchers choose hexarelin vial size wrong because they think in terms of bulk pricing instead of usable peptide. A 20mg vial at $180 looks better than a 5mg vial at $60 when you calculate cost per milligram—until you realize you can only use half of that 20mg vial before it degrades. Then the "savings" become waste. The peptide industry markets larger vials as better value, but that value only materializes if your protocol is long enough and your dosing frequent enough to consume the entire vial within the 28-day post-reconstitution window. For most research applications—particularly initial pilot studies or single-subject trials—smaller vials aren't a compromise. They're the correct choice. The reconstitution stability constraint is non-negotiable, and no amount of careful refrigeration or sterile handling extends that 28-day ceiling meaningfully. Choose hexarelin vial size by working backward from your protocol's total demand and the stability window, not forward from the price list.

Bacteriostatic water doesn't stop time—it buys you four weeks, and that's it. Plan accordingly.